The global lactase market was valued at USD 275 million in 2025. The market is projected to grow from USD 294 million in 2026 to USD 497.8 million by 2034, exhibiting a compound annual growth rate of 6.8% during the forecast period. Contrive Datum Insights presents this information in its report titled "Lactase Market Size, Share & Industry Analysis, By Type (Neutral Lactase, Acid Lactase), Application (Food Industry, Pharmaceutical Industry, Other), Form (Liquid, Powder/Granules), Source (Kluyveromyces lactis (Yeast-derived), Aspergillus-derived (Fungal-derived), Other Microbial Sources), End-use product (Milk & Fluid Dairy, Yogurt & Fermented Products, Cheese & Whey Products, Ice Cream & Frozen Desserts, Lactose-Free Nutritional & Other), and Regional Forecast, 2026-2034".
Lactase is a food-grade enzyme preparation that breaks lactose, the natural sugar in milk, into the simpler sugars glucose and galactose, and is supplied to processors as a liquid concentrate or as a powder or granule preparation dosed directly into dairy or applied during fermentation and cheese-making steps. It is produced in a neutral-pH form for direct addition to fresh milk and dairy beverages and in an acid-stable form suited to whey, cheese and other lower-pH processing streams. Buyers are dairy and food processors formulating lactose-free or lactose-reduced products, ingredient and nutraceutical manufacturers building digestive-health supplements, and specialty food producers that need enzymatic lactose hydrolysis instead of physical separation.
Rising diagnosed and self-identified lactose intolerance
Rising diagnosed and self-identified lactose intolerance is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.8% a year, the type lines exposed to it move fastest: Acid Lactase compounds at 7.95%, taking its share of revenue from 38.15% to 42.01% and its value from USD 104.9 million to USD 209.1 million.
Where the forecast could be beaten: bull case assumes lactose-free SKU introduction and nutraceutical-channel growth continue at the faster end of the recent range, with enzyme pricing holding steady instead of compressing. The study puts that case at USD 564.6 million in 2034, against USD 497.8 million in the base.
On the downside, bear case assumes slower SKU expansion, earlier and broader displacement of enzymatic processing by membrane filtration in large-scale dairy plants, and continued price pressure from cost-constrained processors, which would hold 2034 revenue to USD 434.4 million. Neutral Lactase, which carries 61.85% of 2025 revenue, already grows at only 6.04% against the market's 6.8%, so the largest part of the base is also its slowest.
The Competitive Split Runs by Type
Competition in the global lactase market runs along the type axis, not the regional one. Neutral Lactase holds 61.85% of 2025 revenue at USD 170.1 million and remains the largest line through 2034 at 57.99%, making it the position hardest for a challenger to take. Acid Lactase, growing at 7.95%, is where share actually changes hands. A supplier established in one is not thereby established in the other, so a field of this size persists in a market of USD 275 million.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Food Industry | 68% · USD 187 million | Pharmaceutical Industry 8.67% |
| Form | Liquid | 57.02% · USD 156.8 million | Powder/Granules 7.89% |
| Source | Kluyveromyces lactis (Yeast-derived) | 55.02% · USD 151.3 million | Other Microbial Sources 8.28% |
| End-use product | Milk & Fluid Dairy | 30% · USD 82.5 million | Lactose-Free Nutritional & Other 10.29% |
- Europe was the largest region in 2025, holding 31.85% of global revenue at USD 87.6 million and reaching USD 139.4 million by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24.87% in 2025 to 30% in 2034, with revenue growing from USD 68.4 million to USD 149.3 million.
- At 7.31% of 2025 revenue and 8% by 2034, Middle East and Africa is the smallest region throughout.
- By type, the largest line in 2025 was Neutral Lactase, at 61.85% of revenue and USD 170.1 million.
- Acid Lactase is projected to grow at 7.95% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 57.8 million in 2025, 21.02% of global revenue.
The study covers five axes, by type, and by application, form, source and end-use product, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 434.4 million and USD 564.6 million by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.